10.3109/08923973.2015.1115517 Immunopharmacol Immunotoxicol
3.7 Summary of metabolic outcomes: building foundation for fertility treatment Across available trials, GLP-1RAs consistently improve metabolic drivers that are clinically relevant to fertility planning in PCOS
Patients with a history of malignancy, organ transplantation, or pre-existing dermatologic conditions of interestincluding atopic dermatitis, psoriasis, vitiligo, pemphigus, bullous pemphigoid, dermatomyositis, alopecia areata, lichen planus, cutaneous lupus erythematosus, hidradenitis suppurativa, systemic sclerosis, pyoderma gangrenosum, and morpheawere excluded at baseline
Pray countersued Empower after the company sued him, saying he stole property, made unnecessary purchases and violated his noncompete agreement